Literature DB >> 19237881

Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial.

Didier Payen1, Joaquim Mateo, Jean Marc Cavaillon, François Fraisse, Christian Floriot, Eric Vicaut.   

Abstract

OBJECTIVE: The impact of continuous venovenous hemofiltration on sepsis-induced multiple organ failure severity is controversial. We sought to assess the effect of early application of hemofiltration on the degree of organ dysfunction and plasma cytokine levels in patients with severe sepsis or septic shock.
DESIGN: Prospective, randomized, open, multicenter study setting, 12 French intensive care units. PATIENTS: A total of 80 patients were enrolled within 24 hours of development of the first organ failure related to a new septic insult.
INTERVENTIONS: Patients were randomized to group 1 (HF), who received hemofiltration (25 mL/kg/hr) for a 96-hour period, or group 2 (C) who were managed conventionally.
MEASUREMENTS AND MAIN RESULTS: The primary end point was the number, severity, and duration of organ failures during 14 days, as evaluated by the Sepsis-Related Organ Failure Assessment score, on an intention-to-treat analysis. Strict guidelines were provided to perform continuous hemofiltration under the same conditions and bearing the same objectives in all centers. Because of inclusion stagnation, the trial was discontinued after an interim analysis by which time 76 patients had been randomized. The number and severity of organ failures were significantly higher in the HF group (p < 0.05). No modifications in plasma cytokine levels could be detected.
CONCLUSION: These data suggest that early application of standard continuous venovenous hemofiltration is deleterious in severe sepsis and septic shock. This study does not rule out an effect of high-volume hemofiltration (>35 mL/kg/hr) on the course of sepsis.

Entities:  

Mesh:

Year:  2009        PMID: 19237881     DOI: 10.1097/CCM.0b013e3181962316

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  91 in total

Review 1.  [Results of studies in critical care medicine in the year 2009 : update].

Authors:  M Bernhard; G Marx; K Weismüller; C Lichtenstern; K Mayer; F M Brunkhorst; M A Weigand
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

Review 2.  The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2010-04-10       Impact factor: 2.370

Review 3.  Advances in the management of sepsis and the understanding of key immunologic defects.

Authors:  Lee P Skrupky; Paul W Kerby; Richard S Hotchkiss
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

4.  Does this patient with AKI need RRT?

Authors:  Miet Schetz; Lui G Forni; Michael Joannidis
Journal:  Intensive Care Med       Date:  2015-12-21       Impact factor: 17.440

Review 5.  Renal replacement therapy review: past, present and future.

Authors:  Geoffrey M Fleming
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

Review 6.  Blood purification and mortality in sepsis: a meta-analysis of randomized trials.

Authors:  Feihu Zhou; Zhiyong Peng; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

7.  Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.

Authors:  Zhi-Yong Peng; Hong-Zhi Wang; Melinda J Carter; Morgan V Dileo; Jeffery V Bishop; Fei-Hu Zhou; Xiao-Yan Wen; Thomas Rimmelé; Kai Singbartl; William J Federspiel; Gilles Clermont; John A Kellum
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

Review 8.  [Extracorporeal renal replacement therapy in acute kidney injury : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  V Schwenger; D Kindgen-Milles; C Willam; A Jörres; W Druml; D Czock; S J Klein; M Oppert; M Schmitz; J T Kielstein; A Zarbock; M Joannidis; S John
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-15       Impact factor: 0.840

9.  Sepsis: clearing the blood in sepsis.

Authors:  Jean-Louis Vincent
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

Review 10.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.